Abstract:α‐Phellandrene (α‐PA), a natural constituent of herbs, inhibits cancer cell viability and proliferation. 5‐Fluorouracil (5‐FU) is a frequently utilized chemotherapeutic medicine for the treatment of colon cancer, which works by triggering cancer cell apoptosis. The present study examined how the combination of α‐PA and 5‐FU affects the suppression of human colon cancer cells by promoting apoptosis. The impact of this treatment on cell viability, apoptosis, and the expression levels of Bcl‐2 family members, caspase family members and mitochondria‐related molecules in HT‐29 cells was assessed by the MTT assay, immunocytochemistry, western blotting and quantitative PCR. The combination of 5‐FU and α‐PA had a synergistic inhibitory effect on cell viability, as determined by assessing the combination index value. Bax protein expression levels were higher in the 50, 100 or 250 μM α‐PA combined with 5‐FU groups compared with those in the 5‐FU alone group (P<0.05). By contrast, Bcl‐2 protein expression levels and mitochondrial membrane potential (MMP, ΔΨm) were lower in the 100 or 250 μM α‐PA combined with 5‐FU groups than those in the 5‐FU alone group (P<0.05). In addition, hexokinase‐2 (HK‐2) protein expression levels were lower in the 50, 100 or 250 μM α‐PA combined with 5‐FU groups than those in the 5‐FU alone group (P<0.05). Compared with 5‐FU alone, after HT‐29 cells were treated with 50, 100 or 250 μM α‐PA combined with 5‐FU, the mRNA expression levels of extrinsic‐induced apoptotic molecules, including caspase‐8 and Bid, were higher (P<0.05). Treatment with 50, 100 or 250 μM α‐PA combined with 5‐FU also increased the mRNA expression levels of cytochrome c, caspase‐9 and caspase‐3, regulating intrinsic apoptosis (P<0.05). These results showed that α‐PA and 5‐FU had a synergistic effect on reducing the viability of human colon cancer HT‐29 cells by inducing extrinsic and intrinsic apoptosis pathways. The mechanism by which apoptosis is induced may involve the intrinsic apoptosis pathway that activates the mitochondria‐dependent pathway, including regulating the expression levels of Bcl‐2 family members, including Bax, Bcl‐2 and Bid, regulating MMP and HK‐2 expression levels, and increasing the expression of caspase cascade molecules, including caspase‐9 and caspase‐3. In addition, it may involve the extrinsic apoptosis pathway that activates caspase‐8 and caspase‐3 leading to apoptosis.

Comparative antitumor activity of 5-fluorouracil and its prodrugs in combination with hyperthermia in vitro

Polyunsaturated Fatty Acids Augment Tumoricidal Action Of 5-Fluorouracil On Gastric Cancer Cells By Their Action On Vascular Endothelial Growth Factor, Tumor Necrosis Factor-Alpha And Lipid Metabolism Related Factors

[RAD001 Reverses Radio-Resistance and Exerts Synergistic Tumor Inhibition with 5-Fluorouracil].

THE SYNERGISTIC ANTI-PROLIFERATIVE EFFECT OF CURCUMIN AND FLUOROURACIL ON HUMAN COLON CANCER CELL LINE HT-29

Combined Effect of 5-Fluorouracil and Recombinant Tumor Necrosis Factor Against Human Gastric Carcinoma Cell Lines.

Melatonin Synergizes the Chemotherapeutic Effect of 5‐fluorouracil in Colon Cancer by Suppressing PI3K/AKT and NF‐κB/iNOS Signaling Pathways

Synergistic effect of 5-fluorouracil and the flavanoid oroxylin A on HepG2 human hepatocellular carcinoma and on H22 transplanted mice

Luteolin synergizes the antitumor effects of 5-fluorouracil against human hepatocellular carcinoma cells through apoptosis induction and metabolism

In Vitro Additive Antitumor Effects of Dimethoxycurcumin and 5‐fluorouracil in Colon Cancer Cells

In Vitro Synergistic Interaction Between CLFF and 5-Fluorouracil on Human Gastric Cancer Cell Lines

Synergistic Antitumor Effect of 5-Fluorouracil Combined with Constituents from Pleurospermum Lindleyanum in Hepatocellular Carcinoma SMMC-7721 Cells.

Enhancement of anti-tumor effects of 5-fluorouracil on hepatocellular carcinoma by low-intensity ultrasound

Enhanced Anticancer Activity of 5-Fu in Combination with Bestatin: Evidence in Human Tumor-Derived Cell Lines and an H22 Tumor-Bearing Mouse

Parthenolide Augments the Anticancer Effects of 5-Fluorouracil on Cell Apoptosis and Decreased Nf-Kappa B Activity in A Gastric Cancer Cell Line

α‐Phellandrene enhances the apoptosis of HT‐29 cells induced by 5‐fluorouracil by modulating the mitochondria‐dependent pathway

Weekly Paclitaxel and High-Dose 5-Fluorouracil Plus Leucovorin in Hormone-Refractory Prostate Cancer: in Vitro Combined Effects and a Phase II Trial

H1, a Derivative of Tetrandrine, Enhances the Efficacy of 5-FU in Bel7402/5-FU Cells Via Suppressing STAT3/MCL-1 and Inducing PUMA

Synergistic antitumor effect of puerarin combined with 5-fluorouracil on gastric carcinoma

H1, a derivative of tetrandrine, enhances the efficacy of 5-FU in Bel7402/5-FU cells via suppressing STAT3/MCL-1 and inducing PUMA.

Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators

Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells